Contravisory Investment Management’s Molina Healthcare MOH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$88.7K Buy
+388
New +$70.3K 0.02% 238
2023
Q2
– Sell
-427
Closed -$114K – 346
2023
Q1
$114K Buy
427
+13
+3% +$3.74K 0.03% 215
2022
Q4
$137K Buy
414
+204
+97% +$69.3K 0.04% 208
2022
Q3
$69K Buy
+210
New +$67.6K 0.02% 229
2019
Q3
– Sell
-1,610
Closed -$230K – 296
2019
Q2
$230K Hold
1,610
– – 0.09% 134
2019
Q1
$229K Sell
1,610
-186
-10% -$25.2K 0.09% 136
2018
Q4
$209K Buy
1,796
+96
+6% +$12.6K 0.09% 135
2018
Q3
$253K Hold
1,700
– – 0.09% 131
2018
Q2
$166K Sell
1,700
-96
-5% -$8.37K 0.06% 156
2018
Q1
$146K Buy
+1,796
New +$144K 0.05% 168

Other funds holding MOH

Contravisory Investment Management's MOH Position: Q2 2026 in Review

Contravisory Investment Management opened a new position in Molina Healthcare (MOH) in Q2 2026: 388 shares worth $88.7K. The stake represents 0.02% of the portfolio and ranks #238 among its holdings. This is a return to the name: Contravisory Investment Management previously reported a position in MOH as recently as Q1 2023.

Contravisory Investment Management first reported a position in MOH in Q1 2018 and has held it in 10 quarters since. The position peaked at $253K in Q3 2018. 602 funds tracked by Wall St. Rank hold MOH as of Q2 2026.

  • Contravisory Investment Management held 388 shares of Molina Healthcare worth $88.7K as of Q2 2026.
  • Molina Healthcare was a new Contravisory Investment Management position in Q2 2026.
  • Molina Healthcare made up 0.02% of Contravisory Investment Management's portfolio in Q2 2026, its #238 holding.
  • Contravisory Investment Management first reported a position in Molina Healthcare in Q1 2018 and has held it in 10 quarters since.
  • Contravisory Investment Management's Molina Healthcare position peaked at $253K in Q3 2018.
  • 602 funds tracked by Wall St. Rank held Molina Healthcare as of Q2 2026.

Based on Contravisory Investment Management's 13F filing for Q2 2026, filed 9 Jul 2026.